Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Bharat Biotech International Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

BHARAT BIOTECH INTERNATIONAL LIMITED

Active

Updated: 25 Oct 2024

Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacturing of vaccines and biotherapeutics

Bharat Biotech International Limited, is an unlisted public company incorporated on 15 February, 1996. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 15.07 cr.

Industry

Manufacturing of Pharmaceuticals

Products

a thiomersal free recombinant hepatitis-B vaccine; TEVAC, a tetanus vaccine; Scorgen, a poliomyelitis vaccine; INDIRAB, a vi polysaccharide typhoid vaccine; BIOPOLIO, Revac-B+, a haemophilus influenza type b vaccine., a scorpion venom anti-serum; and BioHib, a recombinant hepatitis-B vaccine; TYPBAR, a rabies vaccine; Revac-Bmcf

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-29.4%

₹ GET PRO

EBITDA

-72.58%

₹ GET PRO

Net Profit

-38.85%

₹ GET PRO

Networth

-8.88%

₹ GET PRO

Borrowings

₹ GET PRO

Assets

-14.92%

₹ GET PRO

Gross Margin

-12.57

GET PRO %

Operating Margin

-17.68

GET PRO %

Net Profit Margin

-3.41

GET PRO %

Return on Equity

-3.41

GET PRO %

ROCE

-7.46

GET PRO %

Debt to Equity

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (7)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	11.8	11.8	11.8	15.1	13.0
Reserves	702.0	1,124.7	4,022.3	5,603.9	5,075.2
Borrowings +	210.4	239.0	1,038.6	-	-
Long term borrowings	2.6	-	-	-	-
Short term borrowings	207.8	239.0	1,038.6	-	-
Trade payables +	124.2	33.2	1,271.8	188.0	123.7
Days payable	200.0	35.0	-1,297.0	136.0	89.0
Other liabilities +	392.3	999.9	3,323.6	1,252.8	753.9
Other non-current liabilities	172.4	644.4	284.2	202.4	76.3
Other current liabilities	95.7	322.3	1,767.6	862.3	553.9
Total liabilities	1,316.5	2,375.3	8,396.2	6,871.8	5,842.1
Fixed Assets +	354.2	925.7	939.2	823.7	631.9
Tangible assets	192.6	792.7	783.1	499.6	503.2
CWIP	118.1	99.9	133.1	180.0	120.2
Intangible assets	43.5	33.0	23.0	144.1	8.4
LT loans and advances	6.2	5.6	35.0	-	264.7
Other non-current assets	219.0	193.9	109.0	1,506.9	1,303.2
Current assets +	737.2	1,250.1	7,313.0	4,541.2	3,642.4
Inventories	216.6	187.1	1,169.8	932.2	652.7
Trade receivables	90.1	110.4	564.7	252.1	397.7
Cash and cash equivalents	372.0	653.5	4,574.2	80.3	205.2
ST loans and advances	0.5	1.6	-	35.0	25.0
Other current assets	57.9	297.5	1,004.3	3,241.5	2,361.8
Total assets	1,316.5	2,375.3	8,396.2	6,871.8	5,842.1

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.89	0.49	0.14	0.22	0.22
Reserves	53.33	47.35	47.91	81.55	86.87
Borrowings +	15.98	10.06	12.37	0.0	0.0
Long term borrowings	0.2	0.0	0.0	0.0	0.0
Short term borrowings	15.78	10.06	12.37	0.0	0.0
Trade payables	9.43	1.4	15.15	2.74	2.12
Other liabilities +	29.8	42.09	39.58	18.23	12.9
Other non-current liabilities	13.1	27.13	3.39	2.95	1.31
Other current liabilities	7.27	13.57	21.05	12.55	9.48
Total liabilities
Fixed Assets +	26.9	38.97	11.19	11.99	10.82
Tangible assets	14.63	33.37	9.33	7.27	8.61
CWIP	8.97	4.21	1.59	2.62	2.06
Intangible assets	3.3	1.39	0.27	2.1	0.14
LT loans and advances	0.47	0.23	0.42	0.0	4.53
Other non-current assets	16.63	8.16	1.3	21.93	22.31
Current assets +	56.0	52.63	87.1	66.08	62.35
Inventories	16.45	7.88	13.93	13.57	11.17
Trade receivables	6.85	4.65	6.73	3.67	6.81
Cash and cash equivalents	28.26	27.51	54.48	1.17	3.51
ST loans and advances	0.04	0.07	0.0	0.51	0.43
Other current assets	4.4	12.52	11.96	47.17	40.43
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	1,079.7	1,500.9	8,116.1	2,001.3	1,323.2
Sales growth %	35.17	39.01	440.74	-75.34	-33.88
Expenses +	705.4	979.5	4,101.7	1,542.1	1,227.6
Cost of goods	226.2	344.2	-358.0	503.9	506.2
Employee cost	89.1	133.4	457.3	186.1	153.7
Other costs	313.4	388.9	3,024.1	728.4	548.9
Operating profit +	451.0	634.5	4,992.7	582.9	114.3
Operating margin %	41.8	42.3	61.5	29.1	8.6
Other income	18.0	47.0	146.8	344.1	304.2
Interest	32.9	44.5	862.8	8.5	1.4
Depreciation	43.7	68.5	115.4	115.2	17.3
Exceptional items	-	-	-	-	-
Profit before tax	392.4	568.4	4,161.2	803.2	399.7
Tax	94.3	146.8	1,265.3	234.6	112.7
Profit - disc. ops	-	-	-	-	-
Net profit	298.0	421.7	2,895.9	574.9	287.1
Net margin %	27.1	27.2	35.0	24.5	17.6

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	98.36	96.96	98.22	85.33	81.31
Expenses +	64.26	63.28	49.64	65.75	75.44
Cost of goods	20.6	22.23	-4.33	21.49	31.11
Employee cost	8.12	8.62	5.53	7.94	9.45
Other costs	28.55	25.12	36.6	31.06	33.73
Operating profit	41.08	40.99	60.42	24.85	7.03
Other income	1.64	3.04	1.78	14.67	18.69
Interest	3.0	2.88	10.44	0.36	0.09
Depreciation	3.98	4.43	1.4	4.91	1.06
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	35.74	36.72	50.36	34.25	24.56
Tax	8.59	9.48	15.31	10.0	6.92
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	27.15	27.24	35.05	24.51	17.64

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.3	0.2	0.3	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0	0.0
Total Debt/Assets	0.2	0.1	0.1	0.0	0.0
Total Assets/Equity	1.8	2.1	2.1	1.2	1.1
Liquidity +
Current Ratio	1.7	2.1	1.8	4.3	5.4
Quick Ratio	1.2	1.8	1.5	3.4	4.4
Interest Coverage	13.7	14.2	5.8	68.3	78.9
Performance
Gross Margin	79.0	77.1	104.4	74.8	61.7
Operating Margin	41.8	42.3	61.5	29.1	8.6
Net Margin	27.1	27.2	35.0	24.5	17.6
Return +
Return on Equity	41.8	37.1	71.8	10.2	5.6
Pre-tax ROCE	61.4	35.8	116.8	10.8	2.7
Return on Assets	22.6	17.8	34.5	8.4	4.9
Pre-tax ROIC	57.0	49.8	120.9	8.3	1.9
Efficiency +
Days Payable	200.0	35.0	-1,297.0	136.0	89.0
Days Inventory	350.0	198.0	-1,193.0	675.0	471.0
Days Receivable	30.0	27.0	25.0	46.0	110.0
Fixed Asset Turnover	3.0	1.6	8.6	2.4	2.1
Total Asset Turnover	0.8	0.6	1.0	0.3	0.2
Working Capital
Cash Conversion Cycle	180.0	190.0	129.0	585.0	492.0
Working Capital Days	105.0	159.0	145.0	637.0	818.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of India

No. of Loans: 1

Total Amount : 176.0 cr

HDFC Bank Limited

No. of Loans: 1

Total Amount : 50.0 cr

CitiBank N.A.

No. of Loans: 1

Total Amount : 25.0 cr

CENTRE FOR TACHNOLOGY DEVELOPMENT

No. of Loans: 1

Total Amount : 0.5 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	176.0 cr	24 May, 2024
HDFC Bank Limited	50.0 cr	25 Sep, 2017
CitiBank N.A.	25.0 cr	28 Mar, 2013
CENTRE FOR TACHNOLOGY DEVELOPMENT	0.5 cr	07 Apr, 1998

Charges

State Bank of India

HDFC Bank Limited

CitiBank N.A.

CENTRE FOR TACHNOLOGY DEVELOPMENT

People

Designation	Name	DIN/PAN	Tenure
Whole-time Director	Krishna Murthy Ella Shareholder	00072071	18 years
Managing Director	Suchitra Ella Shareholder	00090616	18 years
Director	Velagapudi Kavitha Dutt	00139274	5 years
Director	Melappati Chakravarthy	00144869	3 years
Whole-time Director	Sai Prasad Devarajulu	02790648	5 years
Director	Prathivadibhayankaram Ranganathac Rajagopalan	03272757	27 years
Whole-time Director	Krishna Mohan Vadrevu	05222871	13 years
CFO	Srinivas Tadepally Shareholder	<HIDDEN>	10 years
CS	Yedlapati Kurana Priyadarshini	<HIDDEN>	3 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
ELLA FOUNDATION	Active	1.0 L	2	Andhra Pradesh
SAPIGEN BIOLOGIX PRIVATE LIMITED	Active	274.0 Cr	2	Telangana
SKEGEN Management Advisors LLP	Active	50.0 L	1	at
CONRESS LABS (INDIA) PRIVATE LIMITED	Amalgamated	5.1 Cr	2	Telangana
CENTURY BIOLOGICALS PRIVATE LIMITED	Strike Off	1.0 L	2	Karnataka
CLINSOFT RESEARCH AND IMAGING PRIVATE LI MITED	Strike Off	0.0	1	Karnataka
SKEBIO INFRA LLP	Active	105.0 Cr	1	Telangana
RCC LABORATORIES INDIA PRIVATE LIMITED	Active	5.1 Cr	2	Telangana
CHENNAI WILLINGDON CORPORATE FOUNDATION	Active	19,250.0	1	Tamil Nadu
THE K C P LIMITED	Active	12.9 Cr	1	Tamil Nadu
V. RAMA KRISHNA SONS PRIVATE LIMITED	Active	48.0 L	1	Tamil Nadu
K.C.P TECHNOLOGIES LIMITED	Active	90.0 L	1	Tamil Nadu
VELAGAPUDI FOUNDATION	Active	0.0	1	Tamil Nadu
K.C.P. BIO-TECH LIMITED	Amalgamated	3.8 Cr	1	Tamil Nadu
FLO INDUSTRIAL PARK FEDERATION HYDERABAD	Active	50,000.0	1	Telangana
ABI-SHOWATECH (INDIA) PRIVATE LIMITED	Active	7.1 Cr	1	Tamil Nadu
FIVES CAIL-KCP LIMITED	Active	1.0 Cr	1	Tamil Nadu
DCM SHRIRAM INDUSTRIES LIMITED	Active	17.4 Cr	1	Delhi
APOLLO HEALTHCO LIMITED	Active	2,884.9 Cr	1	Tamil Nadu
CENTUM ELECTRONICS LIMITED	Active	12.9 Cr	1	Karnataka
APOLLO HOSPITALS ENTERPRISE LIMITED	Active	71.9 Cr	1	Tamil Nadu
ANDHRA CHAMBER OF COMMERCE	Active	0.0	1	Tamil Nadu
GREEN VILLAGE HOSPITALITY PRIVATE LIMITED	Strike Off	1.0 L	1	Tamil Nadu
CHIMERA INNS AND RESORTS PRIVATE LIMITED	Active	1.0 L	1	Tamil Nadu
ASB RESTAURANTS PRIVATE LIMITED	Strike Off	1.0 L	1	Delhi
OMNI AGATE FARMS & ESTATES PRIVATE LIMITED	Strike Off	75.0 L	1	Tamil Nadu
BIOVEL LIFE SCIENCES PRIVATE LIMITED	Strike Off	7.4 L	1	Karnataka
AVANTHI FOODS PRIVATE LIMITED	Active	1.0 L	1	Tamil Nadu
INCASYS NETWORKS PRIVATE LIMITED	Strike Off	1.0 L	1	Andhra Pradesh
INNOVA AGRI BIO PARK PRIVATE LIMITED	Active	5.1 Cr	1	Karnataka
RCC NUTRA FILL PRIVATE LIMITED	Active	2.0 Cr	1	Karnataka
ODISHA BIOTECH PARK PRIVATE LIMITED	Active	5.4 Cr	1	Orissa
CHIRON BEHRING VACCINES PRIVATE LIMITED	Active	10.0 Cr	3	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
CHIRON BEHRING VACCINES PRIVATE LIMITED	Maharashtra	1997	₹ 10.0 Cr
Bharat Biotech Singapore Pte Ltd	Singapore	-	-

Registered Details

CIN

U24230TG1996PLC023232

PAN

AABCB3822B

Incorporation

1996, 29.2 years

Company Email

cs01@bharatbiotech.com

Paid up Capital

₹ 15.1 Cr

Authorised Capital

₹ 20.0 Cr

AGM

Sep 2023

Type

Public

Non-government Company

FAQ - BHARAT BIOTECH INTERNATIONAL LIMITED

What is the incorporation date of BHARAT BIOTECH INTERNATIONAL LIMITED?

The incorporation date of BHARAT BIOTECH INTERNATIONAL LIMITED is 15 February, 1996

What is the authorized share capital of BHARAT BIOTECH INTERNATIONAL LIMITED?

The authorized share capital of BHARAT BIOTECH INTERNATIONAL LIMITED is INR ₹ 20.0 Cr.

What is the paid-up capital of BHARAT BIOTECH INTERNATIONAL LIMITED?

The paid-up capital of BHARAT BIOTECH INTERNATIONAL LIMITED is INR ₹ 15.1 Cr.

What is the registered address of BHARAT BIOTECH INTERNATIONAL LIMITED?

The registered address of BHARAT BIOTECH INTERNATIONAL LIMITED is GENOME VALLEY,TURKAPALLY, SHAMIRPET MANDAL NA HYDERABAD Telangana - 000000

What is the CIN number of BHARAT BIOTECH INTERNATIONAL LIMITED?

The CIN number of BHARAT BIOTECH INTERNATIONAL LIMITED is U24230TG1996PLC023232.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

BHARAT BIOTECH INTERNATIONAL LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network